Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal grow...

by Hisao Imai, Kyoichi Kaira, Keita Mori, Mie Kotake, Masumi Mitani, Naoko Kawashima, Takeshi Hisada, Koichi Minato
Published 2019-12-01

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment

by Norimitsu Kasahara, Hisao Imai, Ichiro Naruse, Yusuke Tsukagoshi, Mie Kotake, Noriaki Sunaga, Kyoichi Kaira, Toshitaka Maeno, Takayuki Asao, Takeshi Hisada
Published 2020-08-01